Sirnaomics Ltd.
HKSE: 2257.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Hung Fai Poon
- Employees
- 69
- Headquarters
- Gaithersburg, Hong Kong SAR China
- IPO year
- 2021
- Market cap
- HK$666.5M
- Website
- https://www.sirnaomics.com
Loading 2257…
Loading profile data…Frequently asked questions about 2257
What does Sirnaomics Ltd. (2257.HK) do?
Sirnaomics Ltd., an RNA therapeutics biopharmaceutical company, focuses on the discovery and development of product candidates for indications with medical needs in the United Sates and the People's Republic of China. Its lead product candidates include STP705 for the treatment cutaneous squamous cell carcinoma in situ; basal cell carcinoma; cho...
Where does 2257.HK trade?
Sirnaomics Ltd. (2257.HK) trades on the Hong Kong Stock Exchange.
What sector is 2257.HK in?
Sirnaomics Ltd. (2257.HK) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Sirnaomics Ltd.?
Hung Fai Poon is the chief executive officer of Sirnaomics Ltd. (2257.HK).
Where is Sirnaomics Ltd. headquartered?
Sirnaomics Ltd. is headquartered in Hong Kong SAR China.
Does 2257.HK pay a dividend?
Sirnaomics Ltd. (2257.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 2257.HK go public?
Sirnaomics Ltd. (2257.HK) completed its initial public offering in 2021.